Konstantin von Unger

Konstantin von Unger

Signal active

Member Shareholder Committee

Bio

Konstantin von Unger is a an experienced investor in technology companies and an independent Board member. He serves as the Vice Chairman of the Shareholders' Committee at Henkel AG and as the Chairman of the supervisory board at the Henkel Family Office. Konstantin attended London Business School and Brown University.

Location

London, England, United Kingdom, Europe

Social

Primary Organization

Henkel

Henkel

Founded

1876

Investment

15

Lead investment

4

Exits

4

Employees

10001+

Industry

Consumer, Beauty, Fast-Moving Consumer Goods, Personal Care and Hygiene, Cleaning Products

Jobs history

3

TD Cowen

Co-founder & Partner

2001 - Current

Board Member

2000 - 2016

Henkel

Vice Chairman of the Shareholder Committee & Member of the Digital Advisory Board

2022 - Current

Board and Advisor Roles

0

N/A

Invest in regions

Profile Resume

Konstantin von Unger is the Member Shareholder Committee at Henkel, based in Europe. With a background in Consumer, Konstantin von Unger has a rich history of leadership and innovation. Konstantin von Unger studied BA Economics @ Brown University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.

Recommendation from your interest

N/A

Jeremy Stoppelman

Jeremy Stoppelman

Co-founder and CEO

Keith Rabois

Keith Rabois

Managing Director

Benjamin Ling

Benjamin Ling

Founder and General Partner

Nicolas Berggruen

Nicolas Berggruen

Chairman and Founder

Daniel S. Loeb

Daniel S. Loeb

Founder

Investment portfolio

Konstantin von Unger has made 19 investments. Their Latest investment was Seed Round - Arda Therapeutics on Dec 17, 2021

Number of investment

19

Number of exits

5

Personal investment

19

Annouced DateOrganization NameFunding RoundMoney Raised
Dec 20, 2019
Octane AI Octane AI
Seed Round - Octane AI
0
Jan 01, 2021
Flip Flip
Series A - Flip
0
Oct 06, 2021
Valdera Valdera
Seed Round - Valdera
0
Dec 17, 2021
Arda Therapeutics Arda Therapeutics
Seed Round - Arda Therapeutics
0

Partner investment

0

There is no partner investment available on this profile

Exits

5

exit.name XING

XING

XING Is the social network for business professionals. More than 13 million members worldwide – over 6.5 million of whom...

Invest in industries

Recent Activity

There is no recent news or activity for this profile.